Australia Johnson & Johnson's one-dose COVID-19 vaccine won't be coming to Australia
Urgent AstraZeneca Covid vaccine probe lauched after man hospitalised
Australia's medicines regulator has begun an urgent investigation into the AstraZeneca Covid vaccine after a man was hositalised with a rare blood clotting condition. The Therapeutic Goods Administration held talks with British regulators overnight probing whether the 44-year-old's low blood platelets and 22 other similar cases in the UK are linked to the vaccine.Discussions will continue on Saturday between the Australian Health Protection Principal Committee and the Australian Technical Advisory Group on Immunisation.
Johnson & Johnson's one-dose vaccine will not be part of Australia's vaccine rollout, at least for now, after the federal government confirmed it would not purchased any doses from the company.
The vaccine is being widely used in the United States and has the advantage of only requiring one dose, unlike the Pfizer, AstraZeneca and Moderna alternatives which all require two doses.
The federal government had been in talks with the global pharmaceutical giant about potentially acquiring its vaccine, and the company had previouslyto the Therapeutic Goods Administration for provisional registration.
How dangerous is India’s ‘double mutant’ COVID-19 variant?
Dr Khan examines what we know so far about the new variant.I have written extensively about variants originating in the United Kingdom, Brazil, South Africa and New York; this week, it is the turn of India.
The Johnson & Johnson vaccine is based on similar technology to the AstraZeneca vaccine.
A spokesperson for Health Minister Greg Hunt said those similarities were the reason the federal government had decided against pursuing the option any further.
"The [Johnson & Johnson] vaccine is an adenovirus vaccine, the same type of vaccine as the AstraZeneca vaccine," they said in a statement.
"The government does not intend to purchase any further adenovirus vaccines at this time."
The news comes despite the fact the federal government has been considering how to increase Australia's vaccine orders in response to changing advice around the AstraZeneca vaccine.
Under new advice, Pfizer's coronavirus vaccine is thedue to concerns over an extremely small number of cases of a rare blood clotting condition recorded in recipients of the AstraZeneca vaccine.
Australians under 50 SHOULDN'T get the AstraZeneca vaccine
Australia has advised its citizens under 50 against getting the AstraZeneca Covid-19 vaccine after a link was confirmed between the jab and rare blood clots.Scott Morrison made the announcement on Thursday night after receiving a series of recommendations from the Australian Technical Advisory Group on Immunisation dashing hopes every citizen will be vaccinated by the end of October.
Late last week it was confirmed an order for a further 20 million doses of the Pfizer vaccine had been lodged.
Australia has deals in place with Pfizer, AstraZeneca and Novavax, but the Novavax vaccine is yet to be approved.
Millions vaccinated abroad with a single dose
As of April 11, nearly 6.5 million doses of the Johnson & Johnson vaccine had been administered in the United States, according to the US Centers for Disease Control and Prevention.
Because patients only require one dose, full vaccination of a population can be achieved relatively quickly.
The vaccine is approved for use in the European Union, and shipments to Europe reportedly began this week.
At a press conference with the Prime Minister last Friday, Health Department Secretary Brendan Murphy confirmed the government was "still exploring with Johnson & Johnson".
But he also noted that it was a similar type of vaccine to that produced by AstraZeneca.
Last week the European Medicines Agency said it wasin the US associated with the Johnson & Johnson vaccine.
However, Johnson &Johnson said "no clear causal relationship has been established" between the cases and the vaccine.
Karl Stefanovic says he is nervous about getting the AstraZeneca jab .
Today host Karl Stefanovic, 46, said on Monday he would preference waiting for an alternative vaccine such as Pfizer over being administered doses of the AstraZeneca jab.Stefanovic, 46, said on Monday he would preference waiting for an alternative vaccine such as Pfizer over being administered doses of the AstraZeneca jab, when speaking to Professor Kristine Macartney.